Clinical Trial Update: Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing comparative trial evaluating Montelukast vs Ketotifen in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Ketotifen (Ketotifen)
• Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED